Just doing some quick research as somewhat of an envious non-holder at this moment... I'm very bullish on that T/H Ann
First exclusive HDA platform licensing for the pulmonary delivery of a major drug
Imo, the market will be very closely focussed on this mention within that announcement.
Also imo, if any of the big global pharmaceuticals are named in an exclusive license agreement for Stirlings HDA technology platform for the use of cyclodextrins in formulations for lung delivery this thing will fly on open... and you can mark my words on that!
As a non-holder, I'm sure I can't be accused of ramping here.
GL to all holders. Hope your patience will be deservedly rewarded this week.
STI Price at posting:
0.3¢ Sentiment: None Disclosure: Not Held
